Immunotherapy for recurrent pregnancy loss: "standard of care or buyer beware".
作者信息
Hill J A
出版信息
J Soc Gynecol Investig. 1997 Nov-Dec;4(6):267-73.
PMID:9408880
Abstract
摘要
相似文献
1
Immunotherapy for recurrent pregnancy loss: "standard of care or buyer beware".
J Soc Gynecol Investig. 1997 Nov-Dec;4(6):267-73.
2
[Treatment of recurrent spontaneous abortion associated with the antiphospholipid antibody syndrome].
Gynecol Obstet Fertil. 2003 Sep;31(9):789-93. doi: 10.1016/s1297-9589(03)00210-8.
3
[Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome].
Ann Med Interne (Paris). 2000 May;151 Suppl 1:1S51-4.
4
Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
Acta Obstet Gynecol Scand. 1998 Mar;77(3):354-6.
5
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
Arthritis Rheum. 2003 Mar;48(3):728-31. doi: 10.1002/art.10957.
6
The use of allogeneic leukocytes or i.v. IgG for the treatment of patients with recurrent spontaneous abortions.
Transfus Med Rev. 1997 Apr;11(2):85-94. doi: 10.1053/tm.1997.0110085.
7
Antiphospholipid syndrome and pregnancy loss.
Hosp Med. 1998 Aug;59(8):637-9.
8
Treatment of antiphospholipid syndrome in pregnancy.
Lupus. 1998;7 Suppl 2:S95-7. doi: 10.1177/096120339800700221.
9
Autoimmune factors in assisted reproduction.
Minerva Ginecol. 2002 Jun;54(3):217-24.
10
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
Lupus. 1998;7 Suppl 2:S162-5. doi: 10.1177/096120339800700235.
Zotero 插件